Roche’s Vabysmo reports positive outcomes in multiple eye diseases

Roche will present clinical and real-world data for Vabysmo (faricimab) for treating wet age-related macular degeneration (wAMD) and diabetic macular edema (DME) at the 2023 American Society of Retina Specialists (ASRS) Annual Meeting from 28 July to 1 August in Seattle, US.